GSK supports DSAP in "Healing the Nation"
GlaxoSmithKline (GSK), through its Value Health Program, recently observed the 25th foundation year of Drugstores Association of the Philippines (DSAP) by supporting the association’s “Healing the Nation” project.
The program involved medical missions simultaneously conducted in 14 sites all over the country, including impoverished communities in Bulacan, Zamboanga, Davao, Pangansinan, Makati and Tondo. An estimated 8,000 families availed of free consultations with physicians, blood sugar testing and other medical services. To ensure that they are given the necessary medication for their health conditions, GSK’s Value Health program provided the beneficiaries over P 1.5 million worth of its quality medicines for free. Through the health service and medicines provided, members of the community learned the value of taking proper care of their health.
GSK’s Value Health program was established in 2004 to help improve Filipinos’ health by providing them better access to high quality and affordable medicines. Through Value Health, patients are able to benefit from the trusted and proven quality of GSK products at reduced prices. Now on its fifth year, the Value Health continues to provide Filipino patients with affordable and effective treatments for ailments such as cough, bacterial infections and asthma.
"We recognize that millions of Filipinos are affected by common ailments and medical conditions everyday – conditions that can be cured easily if only they had access to high quality, affordable medicines," says Daisy Cembrano, Vice President for Value Health.
"GSK hopes that through the Value Health program and by supporting initiatives such as the "Healing the Nation" project, we are able to help more patients get the quality care they deserve so they can enjoy healthier, happier lives."
Back to top
GSK at a glance
We are the only pharmaceutical company to tackle the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria Our business employs over 100,000 people in 117 countries We make almost four billion packs of medicines and healthcare products every year We screen about 65 million compounds every year in our search for new medicines We supply one quarter of the world's vaccines and by the end of 2007 we had 23 vaccines in clinical development To date, we have donated over 750 million albendazole tablets to help elimitate lymphatic filariasis (elephantiasis) in the world In 2006 we shipped 126 million tablets of preferentially-priced Combivir and Epivir (our HIV treatments) to developing countries Almost 100 countries benefitted from our humanitarian product donations